Ibon Martínez‐Arranz

1.8k total citations
18 papers, 601 citations indexed

About

Ibon Martínez‐Arranz is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Ibon Martínez‐Arranz has authored 18 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Molecular Biology and 6 papers in Hepatology. Recurrent topics in Ibon Martínez‐Arranz's work include Liver Disease Diagnosis and Treatment (10 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Liver Diseases and Immunity (4 papers). Ibon Martínez‐Arranz is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Liver Diseases and Immunity (4 papers). Ibon Martínez‐Arranz collaborates with scholars based in Spain, United States and Netherlands. Ibon Martínez‐Arranz's co-authors include Cristina Alonso, José M. Mato, Miriam Pérez-Cormenzana, Luís Bujanda, Rebeca Mayo, Maria Luz Martínez‐Chantar, Itziar Mincholé, Enara Arretxe, Luis González and José J.G. Marı́n and has published in prestigious journals such as Hepatology, Scientific Reports and Journal of Hepatology.

In The Last Decade

Ibon Martínez‐Arranz

18 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ibon Martínez‐Arranz Spain 12 267 235 161 122 96 18 601
Enara Arretxe Spain 11 329 1.2× 302 1.3× 135 0.8× 120 1.0× 70 0.7× 14 668
Soichiro Saikawa Japan 13 228 0.9× 245 1.0× 76 0.5× 130 1.1× 90 0.9× 26 593
Keane K. Y. Lai United States 16 344 1.3× 264 1.1× 117 0.7× 71 0.6× 125 1.3× 25 741
Tasuku Nakabori Japan 14 173 0.6× 362 1.5× 74 0.5× 110 0.9× 145 1.5× 51 688
Hyo‐Suk Lee South Korea 13 214 0.8× 290 1.2× 63 0.4× 106 0.9× 133 1.4× 24 634
Andrew Dellinger United States 12 349 1.3× 490 2.1× 117 0.7× 71 0.6× 63 0.7× 27 935
David Fernández‐Ramos Spain 18 717 2.7× 309 1.3× 189 1.2× 88 0.7× 122 1.3× 31 1.1k
Dong‐Ju Shin United States 13 359 1.3× 156 0.7× 206 1.3× 163 1.3× 102 1.1× 25 703
Charles D. Calenda United States 9 294 1.1× 335 1.4× 88 0.5× 62 0.5× 74 0.8× 11 675
Andrea Marengo Italy 9 265 1.0× 544 2.3× 159 1.0× 91 0.7× 104 1.1× 12 892

Countries citing papers authored by Ibon Martínez‐Arranz

Since Specialization
Citations

This map shows the geographic impact of Ibon Martínez‐Arranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibon Martínez‐Arranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibon Martínez‐Arranz more than expected).

Fields of papers citing papers by Ibon Martínez‐Arranz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibon Martínez‐Arranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibon Martínez‐Arranz. The network helps show where Ibon Martínez‐Arranz may publish in the future.

Co-authorship network of co-authors of Ibon Martínez‐Arranz

This figure shows the co-authorship network connecting the top 25 collaborators of Ibon Martínez‐Arranz. A scholar is included among the top collaborators of Ibon Martínez‐Arranz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibon Martínez‐Arranz. Ibon Martínez‐Arranz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Iruzubieta, Paula, Rebeca Mayo, Itziar Mincholé, et al.. (2024). One‐step non‐invasive diagnosis of metabolic dysfunction‐associated steatohepatitis and fibrosis in high‐risk population. United European Gastroenterology Journal. 12(7). 919–929. 8 indexed citations
2.
Rodríguez‐Macías, Gabriela, Óscar Briz, Candela Cives-Losada, et al.. (2023). Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy. Cancers. 15(12). 3145–3145. 2 indexed citations
3.
Macı́as, Rocı́o I.R., Luis Muñoz‐Bellvís, Enara Arretxe, et al.. (2020). A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma. Cancers. 12(6). 1433–1433. 20 indexed citations
4.
Herreros‐Villanueva, Marta, Mario Montes, M. Rodríguez-López, et al.. (2020). CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort. Molecular Biology Reports. 47(3). 1583–1588. 13 indexed citations
5.
Matorras, Roberto, Ibon Martínez‐Arranz, Enara Arretxe, et al.. (2019). The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles. Journal of Assisted Reproduction and Genetics. 37(2). 385–394. 20 indexed citations
6.
Bañales, Jesús M., Mercedes Iñarrairaegui, Ander Arbelaiz, et al.. (2019). SAT-425-Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis. Journal of Hepatology. 70(1). e821–e822. 1 indexed citations
7.
Herreros‐Villanueva, Marta, Saray Durán-Sanchón, María Marcuello, et al.. (2019). Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer. Clinical and Translational Gastroenterology. 10(1). e00003–e00003. 78 indexed citations
8.
Reverter, Enric, Juan José Lozano, Cristina Alonso, et al.. (2019). Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis. Liver International. 39(4). 705–713. 14 indexed citations
9.
Morrison, Martine C., Lars Verschuren, Kanita Salic, et al.. (2018). Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice. Hepatology Communications. 2(12). 1513–1532. 53 indexed citations
10.
Bañales, Jesús M., Mercedes Iñarrairaegui, Ander Arbelaiz, et al.. (2018). Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis. Hepatology. 70(2). 547–562. 132 indexed citations
11.
Bril, Fernando, Laura Millán, Srilaxmi Kalavalapalli, et al.. (2018). Use of a metabolomic approach to non‐invasively diagnose non‐alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 20(7). 1702–1709. 37 indexed citations
12.
Michelena, Javier, Cristina Alonso, Ibon Martínez‐Arranz, et al.. (2018). Metabolomics Discloses a New Non-invasive Method for the Diagnosis and Prognosis of Patients with Alcoholic Hepatitis. Annals of Hepatology. 18(1). 144–154. 6 indexed citations
13.
Iruarrizaga‐Lejarreta, Marta, Ibon Martínez‐Arranz, Marta Varela‐Rey, et al.. (2018). Targeting the NAFLD metabolome and the shaping of precision medicine for patients with NASH. Journal of Hepatology. 68. S362–S363. 3 indexed citations
14.
Cubiella, Joaquín, Marc Clos‐Garcia, Cristina Alonso, et al.. (2018). Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer. Cancers. 10(9). 300–300. 15 indexed citations
15.
Cano, Ainara, Zoe Mariñó, Óscar Millet, et al.. (2017). A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients. Scientific Reports. 7(1). 10497–10497. 20 indexed citations
16.
Martínez‐Arranz, Ibon, Rebeca Mayo, Miriam Pérez-Cormenzana, et al.. (2015). Enhancing metabolomics research through data mining. Journal of Proteomics. 127(Pt B). 275–288. 83 indexed citations
17.
Martínez‐Arranz, Ibon, Rebeca Mayo, Miriam Pérez-Cormenzana, et al.. (2015). Data in support of enhancing metabolomics research through data mining. Data in Brief. 3. 155–164. 7 indexed citations
18.
Martinez‐Uña, Maite, Marta Varela‐Rey, Ainara Cano, et al.. (2013). Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis. Hepatology. 58(4). 1296–1305. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enara Arretxe Breakdown of academic impact, for papers by Soichiro Saikawa Breakdown of academic impact, for papers by Keane K. Y. Lai Breakdown of academic impact, for papers by Tasuku Nakabori Breakdown of academic impact, for papers by Hyo‐Suk Lee Breakdown of academic impact, for papers by Andrew Dellinger Breakdown of academic impact, for papers by David Fernández‐Ramos Breakdown of academic impact, for papers by Dong‐Ju Shin Breakdown of academic impact, for papers by Charles D. Calenda Breakdown of academic impact, for papers by Andrea Marengo
Rankless by CCL
2026